Alzheimer’s drug-development pipeline: 2016

Alzheimer¹s drug-development pipeline- 2016.pdf (876.8 KiB)

A Meta-Analysis of Cytokines in Alzheimer’s Disease

W.Swardfager a meta analysis of....pdf (4.0 MiB)

Alzheimer’s dementia begins as a disease of small blood vessels, damaged by oxidative- induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy

Alzheimer´s Demnetica, Vincent T. Marcesi.pdf (261.6 KiB)

Alzheimer’s Disease Biomarkers – Are In-vitro Diagnostics Really Needed?

to the article